HangYu Watson

HangYu Watson

Auto-generated profile, based on publicly available information

HangYu Watson

West Virginia University

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 May 2025 in Immunotherapy
Verified
Journal Article
Closed access
HWHangYu Watson
HangYu Watson
NHNolan Holley
Nolan Holley
TNTabot Ntoung Nkongho
Tabot Ntoung Nkongho
BPBrijesh Patel
Brijesh Patel
To evaluate whether immune checkpoint inhibitor (ICI) therapy is associated with a higher incidence of hypertension (HTN) among cancer patients compared to those not treated with ICIs. This retrospective cohort study utilized data from the TriNetX Research Network, a global database of de-identified electronic health records. Adult patients (≥18 years) with lung, breast, colon, kidney, or skin cancer were categorized based on ICI treatment. Patients with preexisting hypertension were excluded. Propensity score matching (1:1) based on demographics and comorbidities yielded two balanced cohorts of 24,956 patients each. The primary outcome was the incidence of hypertension within one year of cancer diagnosis. The incidence of hypertension was significantly higher in the ICI group (13.2%) compared to the non-ICI group (9.7%). The risk ratio was 1.356 (95% CI: 1.271-1.446), and the odds ratio was 1.410 (95% CI: 1.311-1.516), both with p < 0.001. Kaplan-Meier analysis showed lower hypertension-free survival in the ICI group (log-rank p < 0.001; HR = 1.071). ICI therapy is significantly associated with an increased risk of developing hypertension. These findings support the need for routine cardiovascular monitoring in patients receiving ICI treatment.

1 October 2025 in JACC: Case Reports
Verified
Journal Article
Open access
HWHangYu Watson
HangYu Watson
SBSeher Berzingi
Seher Berzingi
EHEmily Hendricks
Emily Hendricks
MVMegan Vaughan
Megan Vaughan
STSittinun Thangjui
Sittinun Thangjui
DSDavid Schwartzman
David Schwartzman
Electrical storm is a life-threatening condition often requiring antiarrhythmics, sedation, antiadrenergics, and hemodynamic support. In refractory cases, cardiac sympathetic denervation can help reduce arrythmia burden and implantable cardioverter-defibrillator shocks. A 40-year-old man presented with anteroseptal ST-segment elevation myocardial infarction and newly reduced left ventricular ejection fraction and underwent coronary artery bypass grafting during hospitalization. He subsequently developed refractory monomorphic ventricular tachycardia despite treatment with amiodarone, lidocaine, and a left stellate ganglion block. He was successfully treated with bilateral video-assisted thoracoscopic sympathetic ganglionectomy. In patients presenting with electrical storm, particularly those with ischemic cardiomyopathy, bilateral sympathetic ganglionectomy can be an effective treatment when ventricular arrhythmias are refractory to antiarrhythmic drugs and device optimization. This case highlights that bilateral sympathetic ganglionectomy offers more comprehensive autonomic modulation than unilateral block and may provide definitive control of refractory arrhythmias. Temporary blocks may serve as diagnostic or therapeutic bridges to surgical intervention.

1 December 2025 in Radiology: Cardiothoracic Imaging
Verified
Journal Article
Closed access
SASyed Ahmad
Syed Ahmad
HWHangYu Watson
HangYu Watson
MAMaan Awad
Maan Awad
PPPhilippe Pibarot
Philippe Pibarot
JLJonathon Leipsic
Jonathon Leipsic
IZIrfan Zeb
Irfan Zeb
In low-gradient aortic stenosis, diagnostic strategies combining cardiac CT–derived aortic valve area with aortic valve calcium (AVC) or AVC density scores showed comparable diagnostic performance to baseline models of AVC alone or AVC with aortic valve area from echocardiography.

5 August 2025 in medRxiv
Verified
Preprint
Open access
PDF file
HWHangYu Watson
HangYu Watson
SASyed Ahmad
Syed Ahmad
KPKunal N. Patel
Kunal N. Patel
PPPhilippe Pibarot
Philippe Pibarot
JLJonathon Leipsic
Jonathon Leipsic
IZIrfan Zeb
Irfan Zeb
Objectives: To evaluate whether aortic valve calcium (AVC) scoring by cardiac CT can enhance risk stratification and identify high-risk patients among those with moderate aortic stenosis (AS). Background: Moderate AS is traditionally considered benign, yet emerging evidence suggests a subset may experience adverse outcomes similar to those with severe AS. AVC scoring has been validated for diagnosing severe AS but its prognostic value in moderate AS remains unclear. Methods: A retrospective cohort study of 606 patients with moderate aortic stenosis (MAS) for whom aortic valve calcium (AVC) assessment was recommended on echocardiogram reports. Patients were categorized into two groups: those who underwent AVC (n=159) and those who did not (n=447). Primary outcomes included aortic valve replacement (AVR) and all-cause mortality. Secondary outcomes included time to severe AS diagnosis and time to AVR. Results: A significantly higher proportion of patients in the CT cohort reached a diagnosis of severe AS (28.8% vs. 19.9%, p=0.037) and underwent valve intervention (32.6% vs. 14.1%, p<0.001) compared to the no-CT cohort. Patients underwent valve intervention mostly at the severe AS stage. All-cause mortality was markedly lower in the CT cohort (7.6% vs. 24.9%, p<0.001); difference being driven by excess non-cardiovascular mortality in the no-CT cohort (61.0% vs. 7.9%, p2000 AU and females >1200 AU) were more likely to undergo valve intervention compared with non-severe AVC (HR 2.60, 95% CI 1.42-4.74, p=0.002). Patients in the CT cohort were more likely to undergo valve intervention (HR 3.17, CI 2.04-4.91, p<0.001), and had a significantly lower all-cause mortality (HR 0.32, CI 0.16-0.61, p=0.001) compared to the no-CT cohort. Conclusion: A practice algorithm incorporating AVC for risk stratification of MAS patients can lead to better outcomes. Role of AVC based decision-making in patients with MAS needs further study in a randomized trial.